Viral Vectors in Gene Therapy

Diseases

Kenneth Lundstrom¹ 

[1] PanTherapeutics, CH1095 Lutry, Switzerland;

关键词: prevention;    therapy;    immunotherapy;    gene silencing;    clinical trials;    approved drugs;   

DOI  :  10.3390/diseases6020042

来源: DOAJ

【 摘 要 】

Applications of viral vectors have found an encouraging new beginning in gene therapy in recent years. Significant improvements in vector engineering, delivery, and safety have placed viral vector-based therapy at the forefront of modern medicine. Viral vectors have been employed for the treatment of various diseases such as metabolic, cardiovascular, muscular, hematologic, ophthalmologic, and infectious diseases and different types of cancer. Recent development in the area of immunotherapy has provided both preventive and therapeutic approaches. Furthermore, gene silencing generating a reversible effect has become an interesting alternative, and is well-suited for delivery by viral vectors. A number of preclinical studies have demonstrated therapeutic and prophylactic efficacy in animal models and furthermore in clinical trials. Several viral vector-based drugs have also been globally approved.

【 授权许可】

Unknown